| pubmed-article:2935859 | pubmed:abstractText | Intralipid, an intravenous lipid emulsion for high calorie intake used in parenteral nutrition, has been blamed for causing infectious complications in patients and for inhibiting polymorphonuclear chemotaxis in vitro. Our in vitro study shows that Intralipid moderately perturbs polymorphonuclear chemotaxis even though the product is strongly subjected to phagocytosis, as demonstrated by electron microscopy. The in vivo study merely provides evidence of unpredictable individual sensitivity to Intralipid. | lld:pubmed |
